Alejandro Correa‐Paris
Hospital Materno-Infantil, Universitat Autònoma de Barcelona
Papers
2
Total Citations
29
H-Index
2
About
Dr. Alejandro Correa‐Paris is a leading gynecologic oncologist whose work centers on refining surgical staging for endometrial and ovarian cancers, with a particular focus on minimally invasive techniques and patient risk stratification. His most impactful contribution is the STELLA trial, a prospective randomized study that directly compared transperitoneal versus extraperitoneal laparoscopic aortic lymphadenectomy. This landmark work, cited 27 times, provided crucial evidence on the safety and efficacy of these surgical approaches, helping to standardize care in complex pelvic surgeries. More recently, Dr. Correa‐Paris has advanced the field of preoperative risk assessment. His 2023 study introduced a simple radiologic tool—the sagittal abdominal diameter (SAD) measured via MRI—as a reliable surrogate for visceral obesity. This work demonstrated strong accuracy in predicting surgical morbidity following aortic lymphadenectomy, offering a practical, non-invasive method to identify high-risk patients before they enter the operating room. By bridging surgical technique with personalized risk evaluation, Dr. Correa‐Paris continues to shape safer, more effective oncologic care.
Research Focus
Key Achievements
Top Papers
- 1
- 2